Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Prevention specialty page provides infection prevention-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Addressing Issues Surrounding Current Antibiotic Development
James S. Lewis, PharmD, FIDSA, addresses the issues that surround current antibiotic development.
Hospital Epidemiologists Should Continually Tailor Bundles to Ensure Effectiveness
Silvia Munoz-Price, MD, PhD, explains why infection control bundles should evolve as the problems faced by hospital epidemiologists continue to change.
Long-Acting Injectable: An Exciting New Option for HIV Prevention
Alex Rinehart, PhD, explains how the development of a long-acting injectable offers a new preventive option for HIV.
Challenges Faced When Creating a Vaccine for HIV
Hanneke Schuitemaker, PhD, explains the challenges faced when creating a vaccine for HIV.
What Were the Results of the Phase 3 EMERALD Trial?
Magda Opsomer, MD, shares the results of the Phase 3 EMERALD trial for darunavir.
What Makes ABSSSI Antibiotic Iclaprim Unique?
William D. O’Riordan, MD, FACEP, explains what makes iclaprim a unique antibiotic.
What Are the Next Steps for Iclaprim?
David Huang, PhD, MD, explains what the next steps are for iclaprim, an antibiotic developed to treat patients with acute bacterial skin and skin structure infections.
Hospital Epidemiologist: An Undefined Role?
Silvia Munoz-Price, MD, PhD, explains how the undefined role of a hospital epidemiologist can be problematic.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.